Myofibroblasts in the infarct area: concepts and challenges.
about
Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulatesPhysiological Implications of Myocardial Scar StructureMembrane-associated matrix proteolysis and heart failure.Determining the role of fibrosis in hypertrophic cardiomyopathy.Curcumin suppresses transforming growth factor-β1-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways.Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle.Stretching fibroblasts remodels fibronectin and alters cancer cell migrationAldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway.Extracellular matrix and fibroblast communication following myocardial infarction.In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.Fibroblasts in post-infarction inflammation and cardiac repair.The Living Scar--Cardiac Fibroblasts and the Injured Heart.Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.Systematic characterization of myocardial inflammation, repair, and remodeling in a mouse model of reperfused myocardial infarction.Paracrine Effects of Adipose-Derived Stem Cells on Matrix Stiffness-Induced Cardiac Myofibroblast Differentiation via Angiotensin II Type 1 Receptor and Smad7Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis.Fibroblast-myocyte electrotonic coupling: does it occur in native cardiac tissue?Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential.Vitamin D inflammatory cytokines and coronary events: a comprehensive review.Matrix metalloproteinases are involved in cardiovascular diseases.Mechanoregulation of cardiac myofibroblast differentiation: implications for cardiac fibrosis and therapy.Wnt Signaling in Cardiac Disease.Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps.Introduction: Extracellular matrix and cardiovascular remodeling-using microscopy to delineate mechanisms.AMPK in Cardiovascular Diseases.Myocardial and Serum Galectin-3 Expression Dynamics Marks Post-Myocardial Infarction Cardiac Remodelling.Early and short-term triiodothyronine supplementation prevents adverse post-ischemic cardiac remodeling: role of transforming growth factor-β1 and anti-fibrotic miRNA signaling.Mechanical regulation of cardiac fibroblast profibrotic phenotypes.Modification of oxidative stress on gene expression profiling in the rat infarcted heart.MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis.A single injection of protein-loaded coacervate-gel significantly improves cardiac function post infarction.A Multidisciplinary Assessment of Remote Myocardial Fibrosis After Reperfused Myocardial Infarction in Swine and Patients.Imaging transparent intact cardiac tissue with single-cell resolution.Wnt Signaling in Cardiac Remodeling and Heart Failure.Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine.The Therapeutic Potential of Blocking Galectin-3 Expression in Acute Myocardial Infarction and Mitigating Inflammation of Infarct Region: A Clinical Outcome-Based Translational Study.Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis
P2860
Q26865099-C9D20C5F-DE6C-463E-99AC-411D7F56D7DDQ28085424-BAF98A38-EFF3-4CF2-954D-A48C2965226EQ33632033-A39D7B59-376A-4285-8E73-5A02EDAE7553Q34660599-AB4EA77E-1EE8-44BE-BCD5-6615B1B511AAQ34676424-2E7BB80A-0558-4694-B98A-720E0DA0D19CQ35061221-0F163968-6DE3-42DA-9326-63A49219B7B5Q35062322-7378DDDA-9E74-4B22-A19F-3FF0EB8746BBQ36072394-B4A0F5E4-7779-4CC0-B4BF-DB1E07EAC0DEQ36457257-B83934C0-2515-4321-9DF3-36B31E67A73AQ36519844-381B35C1-295B-49C3-8F74-27613AD0FA83Q36522008-6966F65D-6BEC-4AEF-A1E8-61CC83C52ADFQ36535178-306F50BF-C324-4440-866F-8916901B59B8Q36915712-EC3B9F91-E4FF-4AA0-9450-13306A4C8BB5Q37047650-E1372037-6D09-49E1-92C5-1CB94E18CD49Q37310715-5CF23A8A-DD67-4C9E-BEAF-C7F98893FA98Q37629218-E391A4F1-09EE-4FA3-B2D0-AD3DEA7FC16EQ37725769-67222431-5761-44D2-B087-58077CC7388AQ38064702-43270C1E-F641-4562-9FD1-B6DE6E367D08Q38073680-E26D4C3F-E250-4F38-9A5D-545D45958E8EQ38224193-B2134C88-6753-4ABF-A85C-D7D64DE33387Q38532876-CA527F19-9CF4-4747-A6D5-8395F0AA454FQ38542451-61D4C0DC-B642-415A-9F68-25ADD5E44287Q38863047-D1BA0748-03C9-48F9-B125-136300441E86Q38978606-8D8A711C-06EA-4BE7-B950-DE809059F98EQ38998410-DEF95929-F88F-4D48-9235-8A1B5F965EFCQ39017333-3F7CA308-E582-4AFE-8900-70490AD327C6Q39800297-257B7B4B-84AE-4D8D-9A81-2C460E0611BAQ41229985-1B610AF8-FDD8-41E0-9678-3FE4396D26B7Q41959676-9EAE7153-68CE-4B7E-96B5-45CBBBAD7243Q47136571-D9FDD22C-DC91-4717-AB2B-84500C083A31Q50992929-0CD8064F-7F22-4813-A53D-A874E7D0DB74Q51725730-EE4AF307-C4DB-4D7A-9408-D9F3C9585D9EQ52649548-E947E192-8166-4063-BFF9-ADB7A65D2656Q52815224-1CAD9964-7DFB-4641-A541-54E3CDC04A86Q53306185-7EB1DF18-6285-46F3-9FF6-49B739AE6E44Q55035022-DDEB64D0-7DD4-434F-9572-41734F596160Q58127453-4D3E2A22-9836-413E-B606-0966CD36E22B
P2860
Myofibroblasts in the infarct area: concepts and challenges.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Myofibroblasts in the infarct area: concepts and challenges.
@en
Myofibroblasts in the infarct area: concepts and challenges.
@nl
type
label
Myofibroblasts in the infarct area: concepts and challenges.
@en
Myofibroblasts in the infarct area: concepts and challenges.
@nl
prefLabel
Myofibroblasts in the infarct area: concepts and challenges.
@en
Myofibroblasts in the infarct area: concepts and challenges.
@nl
P2093
P2860
P1476
Myofibroblasts in the infarct area: concepts and challenges.
@en
P2093
Ben J A Janssen
Evangelos P Daskalopoulos
W Matthijs Blankesteijn
P2860
P356
10.1017/S143192761101227X
P577
2012-01-04T00:00:00Z